3,175
Views
7
CrossRef citations to date
0
Altmetric
Clinical Study

Chronic kidney disease correlates with MRI findings of cerebral small vessel disease

, , &
Pages 255-263 | Received 09 Mar 2020, Accepted 02 Jan 2021, Published online: 21 Jan 2021

References

  • Arba F, Quinn T, Hankey GJ, the VISTA Collaboration, et al. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack. Eur J Neurol. 2017;24(2):276–282.
  • Doubal FN, MacLullich AM, Ferguson KJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450–454.
  • Boulouis G, Charidimou A, Jessel MJ, et al. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage. Neurology. 2017;88(9):878–884.
  • Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–356.
  • Foster-Dingley JC, Hafkemeijer A, van den Berg-Huysmans AA, et al. Structural covariance networks and their association with age, features of cerebral small-vessel disease, and cognitive functioning in older persons. Brain Connect. 2016;6(9):681–690.
  • Lee M, Saver JL, Chang KH, et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 2010;341(1):c4249–c4249.
  • Toyoda K. Cerebral small vessel disease and chronic kidney disease. J Stroke. 2015;17(1):31–37.
  • Wada M, Nagasawa H, Iseki C, et al. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci. 2008;272(1-2):36–42.
  • Mogi M, Horiuchi M. Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract. 2011;2011:306189.
  • Tu WJ, Dong X, Zhao SJ, et al. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke. J Neuroendocrinol. 2013;25(9):771–778.
  • Astor BC, Hallan SI, Miller ER, 3rd, et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am. J. Epidemiol. 2008;167(10):1226–1234.
  • Engelbertz C, Reinecke H, Breithardt G, et al. Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: the prospective, observational CAD-REF Registry. Int J Cardiol. 2017;243:65–72.
  • Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–838.
  • Hainsworth AH, Fisher MJ. A dysfunctional blood-brain barrier and cerebral small vessel disease. Neurology. 2017;88(5):420–421.
  • Xiao L, Lan W, Sun W, et al. Chronic kidney disease in patients with lacunar stroke: association with enlarged perivascular spaces and total magnetic resonance imaging burden of cerebral small vessel disease. Stroke. 2015;46(8):2081–2086.
  • Miwa K, Tanaka M, Okazaki S, et al. Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology. 2014;82(12):1051–1057.
  • Umemura T, Kawamura T, Umegaki H, et al. Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord Extra. 2013;3(1):212–222.
  • Wang D, Li WB, Wei XE, et al. An investigation of age-related iron deposition using susceptibility weighted imaging. PloS One. 2012;7(11):e50706.
  • Haller S, Bartsch A, Nguyen D, et al. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology. 2010;257(3):764–773.